# twoplus fertility **Source:** https://geo.sig.ai/brands/twoplus-fertility **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** twoplusfertility.com **Last Updated:** 2026-04-14 ## Summary Singapore at-home fertility applicator for natural conception avoiding costly IVF/IUI; YC S20 $5.3M Monk's Hill Ventures-backed revenue-generating 2024 in SG/UK/US competing with Mosie Baby and Natalist for consumer fertility health products. ## Company Overview Twoplus Fertility is a Singapore-based consumer fertility health company — backed by Y Combinator (S20) with $5.3 million raised including a $5.15 million seed round led by Monk's Hill Ventures in May 2022 — providing couples experiencing difficulty conceiving with at-home fertility products designed as non-invasive, affordable alternatives to clinical fertility treatments, starting with the Twoplus Sperm Guide applicator (an at-home cervical cap applicator that positions sperm closer to the cervix during natural conception attempts, increasing the probability of fertilization for couples with mild male factor infertility or unexplained subfertility). Founded in 2019 by Prusothman Raja and Benjamin Tee, Twoplus became revenue-generating in 2024 and distributes products in Singapore, the United Kingdom, and the United States. Twoplus Fertility's product design addresses the accessibility and cost gap between over-the-counter fertility aids (ovulation tests, prenatal vitamins) and clinical fertility treatments (IUI starting at $1,000-3,000 per cycle, IVF starting at $10,000-20,000 per cycle): couples who have been trying to conceive for 6-12 months typically exhaust inexpensive interventions (timing intercourse, lifestyle changes) before the prohibitive cost of clinical fertility procedures drives them to 'try harder' with existing approaches rather than seek medical help. The Twoplus Applicator serves the intervention gap — a clinically informed, at-home device that improves natural conception odds for couples with mild male factor fertility challenges (low sperm count, reduced motility) or cervical mucus barriers by delivering sperm directly past the vaginal canal to the cervical os, replicating the first step of intrauterine insemination (IUI) without the clinic visit. The product launches in Singapore, UK, and US markets where fertility health consumer awareness is high and the customer acquisition cost for the fertility-aware demographic is manageable through digital health channels. In 2025, Twoplus Fertility competes in the consumer fertility, femtech, and at-home fertility treatment market with Mosie Baby (home insemination kit, acquired by Preseed), Natalist (fertility supplement and testing brand, acquired by Hers), and Legacy (male fertility testing, $25M raised) for consumer fertility product spending and digital health adoption. The global fertility treatment market ($24B+ in 2024, projected $38B by 2030) has significant consumer retail opportunity in the pre-clinical intervention tier — couples who will eventually pursue IVF but are looking for lower-cost interventions first represent a large addressable market that clinical fertility practices don't serve economically. Y Combinator S20 backing positioned Twoplus at the intersection of femtech and consumer health. Monk's Hill Ventures' Southeast Asia focus reflects the Singapore fertility health market opportunity and the APAC digital health distribution potential. The 2025 strategy focuses on growing the UK and US direct-to-consumer e-commerce channel, building the subscription model (monthly fertility wellness bundles combining the Applicator with supplements and cycle tracking), and pursuing regulatory clearances for the international market expansion. ## Frequently Asked Questions ### What is twoplus fertility? Twoplus fertility is a Singapore-based healthcare tech company founded in 2019 that provides effective home-use fertility treatment for natural conception. The company offers couples a non-invasive alternative to traditional fertility treatments through at-home fertility products. ### What products and services does twoplus fertility offer? Twoplus fertility offers home-use fertility treatment including a fertility device (Applicator), at-home fertility kits, and non-invasive fertility solutions. These products support natural conception and help couples tackle infertility issues from home. ### Who is twoplus fertility for? Twoplus fertility is designed for couples who are experiencing infertility issues and seeking a non-invasive, at-home alternative to traditional fertility treatments. The products support couples working toward natural conception. ### When was twoplus fertility founded? Twoplus fertility was founded in 2019 by Prusothman Raja and Benjamin Tee. The company was part of Y Combinator's S20 batch. ### Where is twoplus fertility based and available? Twoplus fertility is based in Singapore. The company has expanded its product availability to Singapore, the United Kingdom, and the United States. ### How much funding has twoplus fertility raised? Twoplus fertility has raised $5.3M in total funding, including a $5.15M seed round in May 2022 led by Monk's Hill Ventures. The company is backed by Y Combinator (S20). ### Is twoplus fertility generating revenue? Yes, twoplus fertility became revenue-generating as of February 2024. The company is currently operating in Singapore, the UK, and the USA. ### What technology or approach does twoplus fertility use? Twoplus fertility uses a non-invasive, home-use approach to fertility treatment that supports natural conception. The company's innovation is associated with Stanford Biodesign. ### Who founded twoplus fertility? Twoplus fertility was founded by Prusothman Raja and Benjamin Tee in 2019. The founders participated in Y Combinator's S20 batch. ### What are the recent developments at twoplus fertility? Twoplus fertility completed a $5.15M seed round in May 2022 led by Monk's Hill Ventures and became revenue-generating in February 2024. The company has successfully expanded its availability to three markets: Singapore, the UK, and the USA. ## Tags healthtech, north-america, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*